Article
Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy
30 Dec 2022
Abstract excerpt
Selective serotonin reuptake inhibitors (SSRIs) for treatment of prenatal maternal depression have been associated with neonatal neurobehavioral disturbances, though the molecular mechanisms remain poorly understood. In utero exposure to SSRIs may affect DNA methylation (DNAme) in the human placenta, an epigenetic mark that is established during development and is associated with gene expression. Chorionic villus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
